Columnist Tanita Allen's mindfulness and meditation practice has taught her that she doesn't need to fight herself every ...

Up to four years after a single dose of the experimental gene therapy ifezuntirgene inilparvovec (formerly AMT-130), people with Huntington’s disease who received the high dose showed slower disease ...

Years ago, my wife, Jill, was at a party talking with a friend. The conversation turned personal, and her friend asked a difficult question. It was the kind of question people sometimes ask when they ...

Time-restricted eating (TRE), a form of intermittent fasting that limits daily calorie intake to a six-to-eight-hour window, may help slow the progression of Huntington’s disease, according to results ...

Although there is no cure for Huntington’s disease yet there are several therapeutic approaches that can help manage the symptoms of the disease and maintain patients’ quality of life for as long as ...

There is no cure for Huntington’s disease, nor have any disease-modifying therapies been developed yet that can stop its progression. However, there are approved treatments that can help patients ...

Latus Bio plans to submit an application with the U.S. Food and Drug Administration (FDA) to move LTS-201, a one-time gene therapy for Huntington’s disease, into clinical trials. The application, ...

A single injection of Wave Life Science‘s experimental therapy WVE-003 was found, at either of the two lowest tested doses, to lead to reductions in the mutant huntingtin (mHTT) protein in people with ...

Atalanta Therapeutics has raised $97 million to support planned Phase 1 clinical trials of its experimental RNA interference (RNAi)-based therapies for Huntington’s disease and a genetic form of ...

Several late-stage clinical trials are now recruiting participants to test whether three experimental oral therapies can slow the progression of Huntington’s disease, with active or planned sites in ...

The California Institute for Regenerative Medicine (CIRM) — a state agency created to advance novel treatments for serious medical conditions — has granted nearly $12 million in funding to support a ...